To assess whether hepatic KLB expression is reduced by MASLD disease activity, we performed IHC staining and quantified KLB protein levels in liver biopsies from patients with varying stages of MASLD/MASH. The gene discussed is KLB; the disease is metabolic dysfunction-associated steatotic liver disease.